Home › Funds › JW Asset Management, LLC › HRTX

JW Asset Management, LLC position in HRTX

HERON THERAPEUTICS INC · Health Care

JW Asset Management, LLC reported holding 140,863 shares of HRTX (HERON THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$44K, representing 0.02% of its reported portfolio and ranking #29 among its reported holdings. JW Asset Management, LLC has disclosed HRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)140.86K sh
Reported value held$44.16K
Portfolio Weight0.02%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How JW Asset Management, LLC's HRTX position evolved

JW Asset Management, LLC first disclosed a stake in HRTX in Q3 2023 at 2,407,418 shares (US$2.5M). The position peaked in Q2 2024 at 2,292,418 shares, worth US$8.0M. Across 13 filings, JW Asset Management, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 140,863 shares valued at US$44K — a reduction of -3,610,210 shares quarter over quarter.. Notable position changes include a 41% increase in Q3 2025 (shares rose 3% over the following quarter), a 96% trim in Q3 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.41M $2.48M New
Q4 2023 2.29M $3.90M Reduce
Q1 2024 2.29M $6.35M Hold
Q2 2024 2.29M $8.02M Hold
Q3 2024 2.29M $4.56M Hold
Q4 2024 2.29M $3.51M Hold
Q1 2025 2.34M $5.14M Add
Q2 2025 2.34M $4.84M Hold
Q3 2025 3.29M $4.15M Add
Q4 2025 3.67M $4.77M Add
Q1 2026 3.75M $3.00M Add
Q2 2026 3.75M $1.60M Hold
Q3 2026 140.86K $44.16K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HRTX and 13F data

HRTX (HERON THERAPEUTICS INC) is a Health Care company. 7 other funds we track also report a position in HRTX — the largest reported positions include Velan Capital Investment Management LP (US$3.7M), TANG CAPITAL MANAGEMENT LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HRTX

All HRTX fund holders →

FAQ

How long has JW Asset Management, LLC held HRTX?

JW Asset Management, LLC has disclosed HRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is JW Asset Management, LLC's current position in HRTX?

As of Q3 2026, JW Asset Management, LLC holds 140.86K shares of HRTX (HERON THERAPEUTICS INC), valued at $44.16K, representing 0.02% of its reported portfolio and ranking #29.

Has JW Asset Management, LLC been buying or selling HRTX?

In the latest 13F filing (Q3 2026), JW Asset Management, LLC reduced its position in HRTX. The position peaked in Q2 2024 at 2.29M shares.

Which other funds hold HRTX?

Other major institutional holders of HRTX include Velan Capital Investment Management LP, TANG CAPITAL MANAGEMENT LLC, among 7 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.